Cervical Cancer Screening After 2008

  • Nenad Markovic
  • Olivera Markovic


The manuscript for the book What Every Woman Should Know About Cervical Cancer was submitted for publishing on September 30, 2007. The next month, the 2006 Consensus Guidelines for the Management of Women with Abnormal Cervical Cancer Screening Tests were published in the October issue of the Journal of Lower Genital Tract Disease and in the October 2007 issue of the American Journal of Obstetrics and Gynecology.


Cervical Cancer Cervical Cancer Screening Vaginal Fluid Cervical Cancer Prevention Papanicolaou Staining 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 114.
    Markovic N, Markovic O (2000) CAP-PAP test. US Patent 6,143,512, 20 Nov 2000Google Scholar
  2. 115.
    Markovic O, Markovic N (2003/2004) Cervical acid phosphatase: a biomarker of cervical dysplasia and a potential surrogate endpoint for colposcopy. Dis Markers 19:279–286Google Scholar
  3. 116.
    Markovic N, Markovic O, Sundeen J (2004). BioSciCon Cervical Cancer Study Group. Pap test and a new biomarker-based technology for enhancing the visibility of abnormal cells. 2004 ASCO annual meeting, New Orleans, J Clin Oncol Suppl 22(1):9561. Slide presentation available on Cited September 19, 2007
  4. 117.
    Markovic N, Markovic O, Henderson E et al (2005) MarkPap test for cervical cancer screening. 2005 ASCO annual meeting. J Clin Oncol Suppl 23(1):1021 Slide presentation available on the Internet Cited September 25, 2007
  5. 118.
    Markovic N, Markovic O (2006) The power of the biomarker for cervical cancer control. 2006 ASCO annual meeting. J Clin Oncol Suppl 24:11001(18S). Cited July 7, 2007
  6. 119.
    Markovic N, Markovic O, Henderson E (2006) MarkPap digital, a new prospective for biomarker-based gynecological cytology. Ann meeting of the AACR, April 2006, Washington, DCGoogle Scholar
  7. 120.
    Markovic N, Markovic O (2007). MarkPap test and HPV vaccination. BIO international convention. 2006, innovative corridor, Boston…/Poster/Listing.aspx. www.bioscicon/publications.html. Cited August 1, 2007
  8. 121.
    Markovic O, Markovic N (2007) Will home Pap test be soon available. Experimental biology 2007 annual meeting, Washington, DC. The FASEB J 21(6):708.10Google Scholar
  9. 122.
    Markovic N, Markovic O (2003–2007). publications are available on the Internet at the BioSciCon web site
  10. 135.
    National Cancer Institute. Surveilance Epidemiology and End Results (SEER), cervical cancer, Cited September 12, 2007
  11. 162.
    Solomon D, Davey D, Kurman R et al (2002) The 2001 Bethesda system. Terminology for reporting results of cervical cytology. JAMA 287(16):2114–2119CrossRefPubMedGoogle Scholar
  12. 175.
    World Health Organization (1947) Constitution of the WHO. Chronicles of the WHO, GenevaGoogle Scholar
  13. 178.
    Women in US Government. Challenge to eliminate cervical cancer. Policy Recommendation. Cited on September 29, 2007
  14. 194.
    Markovic O, Shulman NR (1977) Megakaryocyte maturation indicated by methanol inhibition of an acid phospahatase shared by megakariyocytes and platelets. Blood 50:905PubMedGoogle Scholar
  15. 195.
    Markovic N. BioSciCon presents the MarkPap technology. Larta-CAP Venture Forum 2007, San Francisco, May 2007.
  16. 197.
    Markovic N, Markovic O. Ask for women’ s opinion first. Teaching and computer session. FASEB experimental biology, 2008. Today’s research: tomorrow’s health. San Diego California, April 5–9, 2008. Click here to download the abstract
  17. 198.
    Prabal D, Wenkateswaran Y, Bhatla N, Markovic O, Verma K (2008) Cervical acid Phosphatase detection: a guide to abnormal cells in cytology smear screening for cervical cancer. J Cytol 25(1):1–5. Click here to view the article
  18. 200.
    Neha B, Agrawal PM, Santwani M (2015) Staudy of CAPPAP versus conventional papa in suspicious cervical lesions. Int J Res Med 4(1):102–108Google Scholar
  19. 202.
    Markovic O, Markovic N. MarkPap technology: a prospective for global cervical cancer control. FASEB annual meeting, experimental biology 2006, San FranciscoGoogle Scholar
  20. 206.
    Markovic O, Markovic N (2007) Will home Pap test be soon available? Experimental biology 2007. The FASEB J 2007 21(6), A 754, 708.10. Click here to view the article
  21. 207.
    Markovic O, Markovic N (2012) Is mass cytological cancer screening possible worldwide? The FASEB J 26, 657.1. Click here to view the abstract
  22. 208.
    Markovic O, Markovic N. Meeting the recommendations for cervical cancer screening in developing counties. 2014 national conference on cancer detection, diagnosis and treatment for global health. NIH, Bethesda, January 2014. Click here to view
  23. 209.
    Markovic N, Markovic O (2008/2010) What every women should know about cervical cancer. Springer, Dordrecht.
  24. 210. Accessed June 2015
  25. 211.
  26. 212.
  27. 213.
    Markovic O, Markovic N (2013) IT telehealth center for telecytopathology. The FASEB J 27:874.20. Click here to view the abstract
  28. 214.
    Markovic N, Markovic O, Panashchenko O, McJonathan S. A tool for integration of cytology, HPV screening and telecytopathology. BIO 2008 international convention. San Diego, June 2008. Click here to download the abstract
  29. 215.
    Markovic O, Markovic N. IT enables same-day Pap test. Experimental Biology 2009, FASEB, April 2009. Click here to read the abstract
  30. 216.
    Markovic O, Markovic N. Cell phones as a new m-Health opportunity for mass cervical cancer screening. Experimental Biology 2010, FASEB, April 2010. Click here to read the abstract
  31. 217.
    BioSciCon’s most recent advances in wireless telecytopathology. Click here to view the document
  32. 218.
    Markovic O, Markovic N. Further studies on the application of wireless cytopathology for detection of cervical cancer and initial screening for oral cancer. FASEB national meeting, Experimental Biology 2011, Washington, DC, April 2011. Click here to download the abstract
  33. 219.
    Markovic O, Markovic N (2012) Universal adapter for telecytopathology. The FASEB J 26, 1b476. Click here to view the abstract
  34. 220. html. Accessed June 2015
  35. 221.
    MarkPap India, LLC. Fighting cervical cancer in India. Brochure that can be retrieved by clicking on the link.Ch9/1
  36. 222.
    MarkPap Pacific, LLC. Cervical cancer in China. Brochure. Annex. China_13_brochure, F_2.pdf.Ch.9/2Google Scholar
  37. 223.
    Prof. K. Ganapathy. eHealth – The Enterprise of Healthcare Personal Communication 2006–2015Google Scholar
  38. 224.
    Markovic N, Markovic O. MarkPap® test and human papilloma virus infected cells. ASCP annual meeting, 2005Google Scholar
  39. 225.
    Personal communications 2006–2015Google Scholar
  40. 226.
    Markovic N, Markovic O, Sundeen J (2004) Cervical acid phosphatase and Preservecyt®. Inv Med 52(Supp 2):80. See also reference 220, #10Google Scholar
  41. 228.
    Athena HPV Trial. Roche diagnostic medical release. . Retrieved August 2015
  42. 229.
    Cobas 600 Analyzer. Roche diagnostics. Retrieved July 2015
  43. 230.
    Who Statistical Information System. Retrieved June 2015
  44. 231.
    List of counties by GOP per capita. Retrieved June 2015
  45. 232.
    Lantinal Cancer Institute. Surveilance Epidemiology and Results (SEER) Cervical cancer. Retrieved June 2015
  46. 233.
    Markovic N, Markovic O. Cervical Acid Phosphatase-Papanicolaou (CAP-PAP Test). Kit, method and accessories. Processes for producing and using the same. CAP-PAP test kit (short title). Published patent application #10/339.760. PCT. MarkPap system (Method, kit, solution and accessories). FP/W02004/063710Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2016

Authors and Affiliations

  • Nenad Markovic
    • 1
  • Olivera Markovic
    • 2
  1. 1.Global Academy for Women’s Health, Inc.Medical Center DriveRockvilleUSA
  2. 2.Education Global Academy for Women’s Health, Inc.RockvilleUSA

Personalised recommendations